STOCK TITAN

Azitra (AZTR) DEF 14A Filings

AZTR NYSE

Here are the DEF 14A proxy statements from Azitra Inc (AZTR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow AZTR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AZTR filings page.

Rhea-AI Summary

Azitra, Inc. is asking stockholders at its virtual June 4, 2026 annual meeting to approve several major capital structure changes and routine governance items. Stockholders will elect four directors, including CEO Francisco D. Salva and COO Travis Whitfill, and vote on ratifying Grassi & Co., CPAs, P.C. as auditor for 2026.

The company seeks to amend its charter to increase authorized common stock from 200,000,000 to 750,000,000 shares, citing forecasted capital-raising needs to fund product development and other uses. As of April 24, 2026, 16,192,438 shares of common stock were outstanding, with a very large number of additional shares reserved, primarily for warrants.

Azitra also requests authority for the Board to implement one or more reverse stock splits at a ratio between 1-for-2 and 1-for-30 to help support compliance with NYSE American listing requirements. Additional proposals seek NYSE American–required approval for potential issuances of more than 19.99% of outstanding shares under a 2025 Alumni Capital LP agreement and a March 18, 2026 financing involving Series A Preferred Stock and Series B and C Warrants, plus an amendment and restatement of the 2023 Stock Incentive Plan to increase its share reserve and permission to adjourn the meeting if more votes are needed.

Rhea-AI Summary

Azitra, Inc. has called a virtual special stockholder meeting on February 6, 2026 to vote on issuing more than 19.99% of its outstanding common stock under NYSE American rules. The key item is approval of common shares issuable upon exercise of warrants held by Alumni Capital LP under a November 24, 2025 securities purchase agreement. Azitra has already raised about $1.5 million in gross proceeds from this private placement and could receive an additional $1.5 million in gross proceeds if the Alumni Capital warrants are exercised for cash in full, plus about $75,000 if placement agent warrants are fully exercised.

The company states that existing cash and short-term investments, including recent financings, will not fund operating and capital needs for the next twelve months. If it cannot raise additional capital in the very near term, Azitra warns it may need to delay or cut development efforts, reduce marketing, or potentially cease operations and seek protection under the United States Bankruptcy Code. Approval of the proposal would also eliminate an exchange cap limiting issuances to 19.99% and would increase dilution and potential share price volatility for current stockholders. A second proposal would allow adjournment of the meeting to solicit additional proxies if needed.